Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects - PubMed (original) (raw)
Comparative Study
. 1995 May;95(5):2195-204.
doi: 10.1172/JCI117909.
Affiliations
- PMID: 7537758
- PMCID: PMC295829
- DOI: 10.1172/JCI117909
Comparative Study
Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects
L J Goodyear et al. J Clin Invest. 1995 May.
Abstract
To determine whether the impaired insulin-stimulated glucose uptake in obese individuals is associated with altered insulin receptor signaling, we measured both glucose uptake and early steps in the insulin action pathway in intact strips of human skeletal muscle. Biopsies of rectus abdominus muscle were taken from eight obese and eight control subjects undergoing elective surgery (body mass index 52.9 +/- 3.6 vs 25.7 +/- 0.9). Insulin-stimulated 2-deoxyglucose uptake was 53% lower in muscle strips from obese subjects. Additional muscle strips were incubated in the basal state or with 10(-7) M insulin for 2, 15, or 30 min. In the lean subjects, tyrosine phosphorylation of the insulin receptor and insulin receptor substrate-1 (IRS-1), measured by immunoblotting with anti-phosphotyrosine antibodies, was significantly increased by insulin at all time points. In the skeletal muscle from the obese subjects, insulin was less effective in stimulating tyrosine phosphorylation (maximum receptor and IRS-1 phosphorylation decreased by 35 and 38%, respectively). Insulin stimulation of IRS-1 immunoprecipitable phosphatidylinositol 3-kinase (PI 3-kinase) activity also was markedly lower in obese subjects compared with controls (10- vs 35-fold above basal, respectively). In addition, the obese subjects had a lower abundance of the insulin receptor, IRS-1, and the p85 subunit of PI 3-kinase (55, 54, and 64% of nonobese, respectively). We conclude that impaired insulin-stimulated glucose uptake in skeletal muscle from severely obese subjects is accompanied by a deficiency in insulin receptor signaling, which may contribute to decreased insulin action.
Similar articles
- Vanadate enhances but does not normalize glucose transport and insulin receptor phosphorylation in skeletal muscle from obese women with gestational diabetes mellitus.
Shao J, Catalano PM, Yamashita H, Ishizuka T, Friedman JE. Shao J, et al. Am J Obstet Gynecol. 2000 Nov;183(5):1263-70. doi: 10.1067/mob.2000.106816. Am J Obstet Gynecol. 2000. PMID: 11084576 - Molecular determinants of insulin action.
Kahn CR, Folli F. Kahn CR, et al. Horm Res. 1993;39 Suppl 3:93-101. doi: 10.1159/000182793. Horm Res. 1993. PMID: 7505252 Review. - Mechanisms of muscle insulin resistance in obese individuals.
Dohm GL. Dohm GL. Int J Sport Nutr Exerc Metab. 2001 Dec;11 Suppl:S64-70. doi: 10.1123/ijsnem.11.s1.s64. Int J Sport Nutr Exerc Metab. 2001. PMID: 11915930 Review.
Cited by
- Empagliflozin-A Sodium Glucose Co-transporter-2 Inhibitor: Overview ofits Chemistry, Pharmacology, and Toxicology.
Yadav J, Ahsan F, Panda P, Mahmood T, Ansari VA, Shamim A. Yadav J, et al. Curr Diabetes Rev. 2024;20(10):e230124226010. doi: 10.2174/0115733998271026231127051545. Curr Diabetes Rev. 2024. PMID: 38265382 Review. - Insulin Resistance and Hypertension: Mechanisms Involved and Modifying Factors for Effective Glucose Control.
Sakr HF, Sirasanagandla SR, Das S, Bima AI, Elsamanoudy AZ. Sakr HF, et al. Biomedicines. 2023 Aug 15;11(8):2271. doi: 10.3390/biomedicines11082271. Biomedicines. 2023. PMID: 37626767 Free PMC article. Review. - Diagnosis and Non-Invasive Treatment of Obesity in Adults with Type 2 Diabetes Mellitus: A Review of Guidelines.
Łuniewski M, Matyjaszek-Matuszek B, Lenart-Lipińska M. Łuniewski M, et al. J Clin Med. 2023 Jun 30;12(13):4431. doi: 10.3390/jcm12134431. J Clin Med. 2023. PMID: 37445466 Free PMC article. Review. - An Update on the Molecular and Cellular Basis of Pharmacotherapy in Type 2 Diabetes Mellitus.
Mahgoub MO, Ali II, Adeghate JO, Tekes K, Kalász H, Adeghate EA. Mahgoub MO, et al. Int J Mol Sci. 2023 May 26;24(11):9328. doi: 10.3390/ijms24119328. Int J Mol Sci. 2023. PMID: 37298274 Free PMC article. Review. - In Vitro Biological Characterization of Recombinant Insulin Aspart from Biogenomics and Originator Insulin Aspart.
Mishra AG, Deshmane RB, Thappa DK, Lona J, Ghade NS, Sonar SM, Krishnan AR. Mishra AG, et al. BioDrugs. 2023 Sep;37(5):709-719. doi: 10.1007/s40259-023-00607-4. Epub 2023 Jun 7. BioDrugs. 2023. PMID: 37285012
References
- Anal Biochem. 1976 May 7;72:248-54 - PubMed
- J Clin Invest. 1994 Mar;93(3):1156-62 - PubMed
- Science. 1982 Jan 8;215(4529):185-7 - PubMed
- Int J Obes. 1982;6 Suppl 1:73-82 - PubMed
- Proc Natl Acad Sci U S A. 1982 Nov;79(22):6792-6 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous